The global automated cell culture systems Industry is poised for a substantial growth trajectory. With a remarkable Compound Annual Growth Rate (CAGR) of 8.4%, this market is set to expand from its 2022 valuation of US$10.91 billion to an impressive US$20.87 billion by 2030.
Currently, automated cell culture systems account for a substantial 44.5% share of the global cell culture market. This remarkable expansion is being driven by the increasing focus on stem cell research and development, pioneering drug breakthroughs, and a substantial uptick in investments geared toward the development of groundbreaking, innovative products.
The future holds great promise for the global automated cell culture systems market as it continues to play a pivotal role in the advancement of science, medicine, and biotechnology. With unprecedented growth and innovation on the horizon, this market is set to revolutionize the field of cell culture.
Request a Sample Copy of the Report Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-7860
Key Takeaways from the Automated Cell Culture Systems Market
- Consumables are expected to reach US$ 11 Bn by 2030
- Academic institutes are expected to take greater interest in research related to cell culture over the forecast period due to increased government funding in developed countries
- North America and Europe collectively accounted for more than 60% of market share in 2019
- Infinite cell line cultures held close to 75% of market share in 2019
New Product Launches to Remain Key Strategic Focus of Market Players
Players in the automated cell culture systems market are focusing on new product launches to expand their global footprint and strengthen their product portfolio.
For instance –
- In Jun 2020, faCellitate announced the launch of “BIOFLOAT”, it’s very first product to improve 3D cell culture.
- In Mar 2020, BioProcess International started implementing single-use miniature bioreactors for supporting intensified cell culture by using functional performance indicators for assessing small-scale model
- Corning Incorporated, in Oct 2019, came up with Corning Elplasia Plates and Matrigel for organoid culture. It was an addition to its 3D cell culture portfolio
- Ori Biotech has started developing an automated way of manufacturing cell and gene therapies
- In May 2020, Sartorius announced the launch of the Incucyte SX5® for live-cell analysis, for live-cell analysis experiments
Discovering the assumptions behind the study. Ask an Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-7860
Automated Cell Culture Systems Market: Competitive Insights
The global automated cell culture systems market is set to expand its scope in the forecast period, stimulated by increasing drug discovery research and diverse applications of cell lines for research purposes. Furthermore, automated cell culture systems are used for experiments in drug discovery research and in the cell banking process. In addition, cost-effectiveness and the rise in alternative methods for traditional cell culture production are augmenting the adoption of automated cell culture systems.
Key market players covered in the market include Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Tecan Trading AG, Hamilton Medical AG., Biospherix and Promocell GmbH. Key players integrate their positions through acquisitions, mergers, and new product launches.
Key Segments of Automated Cell Culture Systems Industry Survey
Automated Cell Culture Systems Market by Product:
- Automated Cell Culture Storage Equipment
- Automated Cell Culture Vessels
- Bioreactors
- Consumables
Automated Cell Culture Systems Market by Cell Culture:
- Finite Cell Line Cultures
- Infinite Cell Line Cultures
Automated Cell Culture Systems Market by Application:
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
Request a TOC
https://www.futuremarketinsights.com/toc/rep-gb-7860
Automated Cell Culture Systems Market by End User:
- Biotech Companies
- Research Organizations
- Academic Institutes
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
